Jay Johnson
Advertisement
Articles by Jay Johnson
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Zai Lab’s Long-Acting Atopic Dermatitis Bispecific Points to Every-12-Week Dosin
2
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
3
FDA Grants Kamau RMAT Designation to Nula-cel for Sickle Cell Disease
4
Ionis Reports 2-Year Donidalorsen (Dawnzera) Data in HAE Prophylaxis
5